Cargando…

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review

Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced glycation end-products. Expression of high mob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Austin, Bhavsar, Sheila, Riley, Erinn, Caponetti, Gabriel, Agrawal, Devendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Publicações Ltda 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063723/ https://www.ncbi.nlm.nih.gov/pubmed/27746844 http://dx.doi.org/10.1055/s-0036-1583168

Ejemplares similares

Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review
por: Nguyen, Austin H., et al.
Publicado: (2017)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation
por: Tancharoen, Salunya, et al.
Publicado: (2014)

High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon
por: Schoenfeld, Julia, et al.
Publicado: (2023)

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
por: Singh, Harbinder, et al.
Publicado: (2022)

High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia
por: Achouiti, Ahmed, et al.
Publicado: (2013)

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis
por: Mardente, Stefania, et al.
Publicado: (2018)

Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis
por: de Souza, Alexandre W. S., et al.
Publicado: (2014)

High-mobility group box 1 facilitates migration of neural stem cells via receptor for advanced glycation end products signaling pathway
por: Xue, Xin, et al.
Publicado: (2018)

Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients
por: Tang, Kuo-Tung, et al.
Publicado: (2017)

High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars
por: Lee, Dylan E., et al.
Publicado: (2015)

High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products
por: Nadatani, Yuji, et al.
Publicado: (2013)

The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
por: Bobek, Dubravka, et al.
Publicado: (2014)

Modulation of Vagal Sensory Neurons via High Mobility Group Box-1 and Receptor for Advanced Glycation End Products: Implications for Respiratory Viral Infections
por: Mazzone, Stuart B., et al.
Publicado: (2021)

Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2011)

Expression of the Receptor for Advanced Glycation End Products, a Target for High Mobility Group Box 1 Protein, and its Role in Chronic Recalcitrant Rhinosinusitis with Nasal Polyps
por: Dzaman, Karolina, et al.
Publicado: (2014)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
por: Li, Lingzhao, et al.
Publicado: (2022)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023)

Overexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma
por: Mohajertehran, Farnaz, et al.
Publicado: (2018)

High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancer
por: Nakamura, Tomoya, et al.
Publicado: (2020)

High mobility group box-1 and its clinical value in breast cancer
por: Sun, Shanping, et al.
Publicado: (2015)

High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4
por: Wang, Chen, et al.
Publicado: (2015)

High-mobility group box 1 protein is implicated in advanced glycation end products–induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5
por: Lee, Jong-Jer, et al.
Publicado: (2012)

Prognostic value of the high-mobility group box-1 in young patients with chest pain
por: Haghjooy-Javanmard, Shaghayegh, et al.
Publicado: (2014)

International Federation of Head Neck Oncology Society 5(th) World Congress/American Head Neck Society 2014 update
por: Sharma, Shilpi, et al.
Publicado: (2014)

Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study
por: Zakiyanov, Oskar, et al.
Publicado: (2013)

Advanced Glycation End-Products and Their Effects on Gut Health
por: Phuong-Nguyen, Kate, et al.
Publicado: (2023)

Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies
por: Chen, Jie-Hua, et al.
Publicado: (2018)

Diagnostic Values of Advanced Glycation End Products and Homocysteine in Patients with Alzheimer's Disease and Sarcopenia
por: Zhang, Xuelian, et al.
Publicado: (2022)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Clinical Features and Treatment of Fibrous Histiocytomas of the Tongue: A Systematic Review
por: Nguyen, Austin, et al.
Publicado: (2018)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway
por: Zhang, Yulong, et al.
Publicado: (2019)

Value and Quality of Care in Head and Neck Oncology
por: Takes, Robert P., et al.
Publicado: (2020)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Receptor for Advanced Glycation End Products - Membrane Type1 Matrix Metalloproteinase Axis Regulates Tissue Factor Expression via RhoA and Rac1 Activation in High-Mobility Group Box-1 Stimulated Endothelial Cells
por: Sugimoto, Koichi, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Outcomes of Venous End‐to‐Side Microvascular Anastomoses of the Head and Neck
por: Stewart, Matthew, et al.
Publicado: (2020)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_acgo89nvn1f9l2tubu2apbispu